Simultaneous sulfamethoxazole biodegradation and nitrogen conversion in low C/N ratio pharmaceutical wastewater by Achromobacter sp. JL9.
The pharmaceutical industry produces large volumes of low C/N ratio wastewater that is difficult to treat. In this study, we isolated Achromobacter sp. JL9 with high efficiency for sulfamethoxazole degradation and nitrogen conversion in low C/N ratio pharmaceutical wastewater. The SMX biodegradation and nitrogen removal ratio were 92.4% (nitrate-N), 86.7% (ammonia-N), 89.4% (total nitrogen), and 90.4% (SMX). The reaction kinetics and reaction rate constant were C/N ratio-, SMX concentration-, and dissolved oxygen concentration-dependent, and the highest reaction rate constant for SMX biodegradation was 0.0384 min-1. Gaseous compounds analysis and Nap gene amplification analysis by gas chromatography (GC) and polymerase chain reaction (PCR), respectively, showed N2 as an end product during nitrogen conversion. Moreover, toxicity assays were conducted by the inhibition percentage (PI) and agar well diffusion methods. The toxicity of the medium gradually decreased, falling within the nontoxic range after 96 h. The present study showed that biological technologies could be an effective, economical, and environmentally friendly remediation against pharmaceutical pollutants.